A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: Effect on safety and efficacy

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 120, Issue 2, 2005, Pages 185-189

  Xavier, Pedro ^a   Gamboa, Cristina ^a   Calejo, Lucinda ^a   Silva, Joaquina ^a   Stevenson, David ^a   Nunes, Adelina ^a   Martinez De Oliveira, José ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Agonist; Controlled ovarian stimulation; GnRH antagonist

Indexed keywords

BUSERELIN; CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CHI SQUARE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED OVARY STIMULATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE; PHASE 3 CLINICAL TRIAL; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; STATISTICAL SIGNIFICANCE; STUDENT T TEST; UNIVERSITY HOSPITAL;

EID: 19744380301     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.11.005     Document Type: Article

References (11)

1. P. Devroy GnRH antagonists Fertil. Steril. 73 1 2000 15 17
2. N.R. Varney, C. Syrop, C.S. Kubu, M. Struchen, S. Hahn, and K. Franzen Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism J Assis Reprod Genet. 10 1 1993 53 57
3. The North American Ganirelix Study Group Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation Fertil Steril. 75 1 2001 38 45
4. E. Hernandez Embryo implantation and GnRH antagonists: embryo implantation: The Rubicon for GnRH antagonists Hum Reprod. 15 2000 1211 1216
5. S. Kol Embryo implantation and GnRH antagonists: GnRH antagonists in ART: lower embryo implantation? Hum Reprod. 15 2000 1881 1882
6. Z. Blumenfeld Gonadotropin-releasing hormone antagonists instead of agonists: a change for the better? Fertil Steril. 76 3 2001 443 444
7. A. Golan, R. Ron-el, A. Herman, Y. Soffer, Z. Weinraub, and E. Caspi Ovarian hyperstimulation syndrome: an update review Obstet Gynecol Surv. 44 1989 430 440
8. F. Olivennes, R. Fanchin, P. Bouchard, J. Taieb, J. Selva, and R. Frydman Scheduled administration of GnRH antagonist (cetrorelix) on day 8 of in vitro fertilization cycles: a pilot study Hum Reprod. 10 1995 1382 1386
9. K. Diedrich, C. Diedrich, and E. Santos Suppression of the endogenous luteinizing hormone surge by the gonadotropin-releasing hormone antagonist Cetrorelix during ovarian stimulation Hum Reprod. 9 1994 788 791
10. E.M. Casan, F. Raga, F. Bonilla-Musoles, and M.L. Polan Human oviductal gonadotropin-releasing hormone: possible implications in fertilization, preimplantation embryonic development and implantation J Clin Endocrinol Metab. 85 2000 1377 1381
11. C. Albano, R. Felberbaum, and J. Smitz On behalf of the European Cetrorelix Study Group. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin Hum Reprod. 3 2000 526 531